Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
26.4M
-
Shares change
-
+1.08M
-
Total reported value, excl. options
-
$518M
-
Value change
-
+$9.46M
-
Put/Call ratio
-
0.08
-
Number of buys
-
46
-
Number of sells
-
-35
-
Price
-
$19.63
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q4 2021
102 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q4 2021.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.4M shares
of 58.5M outstanding shares and own 45.11% of the company stock.
Largest 10 shareholders include FMR LLC (3.92M shares), WELLINGTON MANAGEMENT GROUP LLP (3.23M shares), Soleus Capital Management, L.P. (2.52M shares), VANGUARD GROUP INC (2.26M shares), JANUS HENDERSON GROUP PLC (1.74M shares), Cormorant Asset Management, LP (1.68M shares), BlackRock Inc. (1.59M shares), STATE STREET CORP (1.13M shares), GREAT POINT PARTNERS LLC (864K shares), and BAKER BROS. ADVISORS LP (825K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.